20294-50-2 Usage
General Description
4-bromo-2-methyl-6-nitrophenol is a chemical compound with the molecular formula C7H6BrNO3. It is a yellow crystalline solid that is commonly used as a reagent in organic and pharmaceutical synthesis. 4-bromo-2-methyl-6-nitrophenol is a derivative of phenol and its structure consists of a nitro group, a bromine atom, and a methyl group attached to a phenol ring. It is a versatile compound that has several applications in the field of chemistry, including as a building block for the synthesis of various pharmaceuticals and agrochemicals. Additionally, it is also used as a substrate for the detection and quantification of nitroreductase enzymes in biological systems. The compound is considered to be moderately toxic and should be handled and used with caution in a laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 20294-50-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,2,9 and 4 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 20294-50:
(7*2)+(6*0)+(5*2)+(4*9)+(3*4)+(2*5)+(1*0)=82
82 % 10 = 2
So 20294-50-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H6BrNO3/c1-4-2-5(8)3-6(7(4)10)9(11)12/h2-3,10H,1H3
20294-50-2Relevant articles and documents
THERAPEUTIC COMPOUNDS AND METHODS OF USE
-
Paragraph 0853; 0854; 0855, (2021/05/21)
The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
-
Paragraph 00888, (2018/09/12)
Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
SUBSTITUTED NITROGEN CONTAINING COMPOUNDS
-
Page/Page column 94, (2019/01/05)
Disclosed are compounds of Formula (I): or a salt thereof, Formula (II) wherein R1 is: or; each W is independently NR1b or O; Z is a bond or CHR1d; and R1, R2, Rd, R3a, R3b, L1, B, V, Y, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of ROMK, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating cardiovascular diseases.
